TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T17569	Voltage-gated potassium channel Kv1.5	D0X4RN	Lidocaine	Approved	3676	C14H22N2O	234.34	CCN(CC)CC(=O)NC1=C(C=CC=C1C)C	IC50 = 2188000 nM	Non binder
T17569	Voltage-gated potassium channel Kv1.5	BVJH09	1-[(2S)-2-Amino-2-[(1r,4S)-4-[({3-oxo-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-6-yl}methyl)amino]cyclohexyl]ethyl]-7-methoxy-1,2-dihydro-1,5-naphthyridin-2-one	Investigative	46205341	C25H30N6O4	478.5	COC1=CC2=C(C=CC(=O)N2C[C@@H](C3CCC(CC3)NCC4=NC5=C(C=C4)OCC(=O)N5)N)N=C1	IC50 > 333000 nM	Non binder